TENAX THERAPEUTICS, INC. Research and Development Expense
TENAX THERAPEUTICS, INC. (TENX) reported Research and Development Expense of $12.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-31
- TENAX THERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $12.85M, a 109.93% increase year-over-year.
- TENAX THERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $11.54M, a 103.04% increase year-over-year.
- TENAX THERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $10.54M, a 129.43% increase year-over-year.
- TENAX THERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $10.33M, a 231.88% increase year-over-year.
- TENAX THERAPEUTICS, INC. research and development expense for fiscal 2025 was $32.67M, a 157.08% increase from fiscal 2024.
- TENAX THERAPEUTICS, INC. research and development expense for fiscal 2024 was $12.71M, a 293.59% increase from fiscal 2023.
- TENAX THERAPEUTICS, INC. research and development expense for fiscal 2023 was $3.23M, a 39.95% decline from fiscal 2022.
- TENAX THERAPEUTICS, INC. research and development expense for fiscal 2022 was $5.38M, a 78.62% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 530 month | Research and Development Expense 533 month | Research and Development Expense 536 month | Research and Development Expense 539 month | Research and Development Expense 542 month | Research and Development Expense 545 month | Research and Development Expense 554 month | Research and Development Expense 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.85M 10-Q · filed 2026-07-31 | $24.39M 10-Q · filed 2026-07-31 | $34.93M derived: sum of 3 quarters · filed 2026-07-31 | $45.26M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2026-03-31 | $11.54M 10-Q · filed 2026-05-12 | $22.08M derived: sum of 2 quarters · filed 2026-05-12 | $32.41M derived: sum of 3 quarters · filed 2026-05-12 | $38.53M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2025-12-31 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $20.87M derived: sum of 2 quarters · filed 2026-03-10 | $26.99M derived: sum of 3 quarters · filed 2026-07-31 | $32.67M 10-K · filed 2026-03-10 | |||||||||||||
| 2025-09-30 | $10.33M 10-Q · filed 2025-11-12 | $16.45M derived: sum of 2 quarters · filed 2026-07-31 | $22.13M 10-Q · filed 2025-11-12 | $26.73M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2025-06-30 | $6.12M 10-Q · filed 2026-07-31 | $11.80M 10-Q · filed 2026-07-31 | $16.40M derived: sum of 3 quarters · filed 2026-07-31 | $19.51M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2025-03-31 | $5.68M 10-Q · filed 2026-05-12 | $10.28M derived: sum of 2 quarters · filed 2026-05-12 | $13.39M derived: sum of 3 quarters · filed 2026-05-12 | $15.72M derived: sum of 4 quarters · filed 2026-05-12 | |||||||||||||
| 2024-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $7.71M derived: sum of 2 quarters · filed 2026-03-10 | $10.03M derived: sum of 3 quarters · filed 2026-03-10 | $12.71M 10-K · filed 2026-03-10 | |||||||||||||
| 2024-09-30 | $3.11M 10-Q · filed 2025-11-12 | $3.11M 10-Q · filed 2024-11-13 | $5.44M derived: sum of 2 quarters · filed 2025-11-12 | $8.12M 10-Q · filed 2025-11-12 | $8.12M 10-Q · filed 2024-11-13 | $9.81M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||
| 2024-06-30 | $2.33M 10-Q · filed 2025-08-13 | $2.33M 10-Q · filed 2024-08-13 | $5.00M 10-Q · filed 2025-08-13 | $5.00M 10-Q · filed 2024-08-13 | $6.70M derived: sum of 3 quarters · filed 2025-08-13 | $7.77M derived: sum of 4 quarters · filed 2025-08-13 | |||||||||||
| 2024-03-31 | $2.68M 10-Q · filed 2025-05-14 | $2.68M 10-Q · filed 2024-05-14 | $4.38M derived: sum of 2 quarters · filed 2025-05-14 | $5.44M derived: sum of 3 quarters · filed 2025-05-14 | $5.64M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||||||
| 2023-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $2.77M derived: sum of 2 quarters · filed 2025-03-25 | $2.96M derived: sum of 3 quarters · filed 2025-03-25 | $3.23M 10-K · filed 2025-03-25 | $3.23M 10-K · filed 2024-03-28 | ||||||||||||
| 2023-09-30 | $1.07M 10-Q · filed 2024-11-13 | $1.26M derived: sum of 2 quarters · filed 2024-11-13 | $1.53M 10-Q · filed 2024-11-13 | $2.66M derived: sum of 4 quarters · filed 2024-11-13 | |||||||||||||
| 2023-06-30 | $197.90K 10-Q · filed 2024-08-13 | $463.64K 10-Q · filed 2024-08-13 | $1.60M derived: sum of 3 quarters · filed 2024-08-13 | $3.14M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||
| 2023-03-31 | $265.74K 10-Q · filed 2024-05-14 | $1.40M derived: sum of 2 quarters · filed 2024-05-14 | $2.94M derived: sum of 3 quarters · filed 2024-05-14 | $4.47M derived: sum of 4 quarters · filed 2024-05-14 | |||||||||||||
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.68M derived: sum of 2 quarters · filed 2024-03-28 | $4.20M derived: sum of 3 quarters · filed 2024-03-28 | $5.38M 10-K · filed 2024-03-28 | |||||||||||||
| 2022-09-30 | $1.54M 10-Q · filed 2023-11-13 | $3.06M derived: sum of 2 quarters · filed 2023-11-13 | $4.24M 10-Q · filed 2023-11-13 | $5.16M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-06-30 | $1.52M 10-Q · filed 2023-08-14 | $2.70M 10-Q · filed 2023-08-14 | $3.62M derived: sum of 3 quarters · filed 2023-08-14 | $4.78M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||
| 2022-03-31 | $1.18M 10-Q · filed 2023-05-15 | $2.09M derived: sum of 2 quarters · filed 2023-05-15 | $3.26M derived: sum of 3 quarters · filed 2023-05-15 | $3.95M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||||
| 2021-12-31 | $915.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.08M derived: sum of 2 quarters · filed 2023-03-31 | $2.77M derived: sum of 3 quarters · filed 2023-03-31 | $25.15M 10-K · filed 2023-03-31 | |||||||||||||
| 2021-09-30 | $1.16M 10-Q · filed 2022-11-10 | $1.86M derived: sum of 2 quarters · filed 2022-11-10 | $24.23M 10-Q · filed 2022-11-10 | $25.12M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||||||
| 2021-06-30 | $693.22K 10-Q · filed 2022-08-11 | $23.07M 10-Q · filed 2022-08-11 | $23.96M derived: sum of 3 quarters · filed 2022-08-11 | $25.01M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||||||
| 2021-03-31 | $22.38M 10-Q · filed 2022-05-16 | -$22.38M 10-Q · filed 2021-05-17 | $23.27M derived: sum of 2 quarters · filed 2022-05-16 | $24.32M derived: sum of 3 quarters · filed 2022-05-16 | $25.59M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | $890.96K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $1.94M derived: sum of 2 quarters · filed 2022-03-29 | $3.22M derived: sum of 3 quarters · filed 2022-03-29 | $4.56M 10-K · filed 2022-03-29 | |||||||||||||
| 2020-09-30 | $1.05M 10-Q · filed 2021-11-15 | -$1.05M 10-Q · filed 2020-11-16 | $2.33M derived: sum of 2 quarters · filed 2021-11-15 | $3.67M 10-Q · filed 2021-11-15 | -$3.67M 10-Q · filed 2020-11-16 | $6.50M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||
| 2020-06-30 | $1.27M 10-Q · filed 2021-08-16 | -$1.27M 10-Q · filed 2020-08-14 | $2.62M 10-Q · filed 2021-08-16 | -$2.62M 10-Q · filed 2020-08-14 | $5.45M derived: sum of 3 quarters · filed 2021-08-16 | $4.54M derived: sum of 4 quarters · filed 2021-08-16 | |||||||||||
| 2020-03-31 | -$1.34M 10-Q · filed 2021-05-17 | $4.18M derived: sum of 2 quarters · filed 2021-05-17 | $3.26M derived: sum of 3 quarters · filed 2021-05-17 | $2.61M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||||||
| 2019-12-31 | $5.52M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $4.60M derived: sum of 2 quarters · filed 2021-04-16 | $3.95M derived: sum of 3 quarters · filed 2021-04-16 | $3.47M 10-K/A · filed 2021-04-16 | |||||||||||||
| 2019-09-30 | -$916.98K 10-Q · filed 2020-11-16 | -$1.57M derived: sum of 2 quarters · filed 2020-11-16 | -$2.05M 10-Q · filed 2020-11-16 | -$77.34K derived: sum of 4 quarters · filed 2020-11-16 | |||||||||||||
| 2019-06-30 | -$649.25K 10-Q · filed 2020-08-14 | -$1.13M 10-Q · filed 2020-08-14 | $839.64K derived: sum of 3 quarters · filed 2020-08-14 | $477.02K derived: sum of 4 quarters · filed 2020-08-14 | |||||||||||||
| 2019-03-31 | -$482.77K 10-Q · filed 2020-05-15 | $1.49M derived: sum of 2 quarters · filed 2020-05-15 | $1.13M derived: sum of 3 quarters · filed 2020-05-15 | $815.12K derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||||
| 2018-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.61M derived: sum of 2 quarters · filed 2020-03-30 | $1.30M derived: sum of 3 quarters · filed 2020-03-30 | $1.24M 10-K · filed 2020-03-30 | |||||||||||||
| 2018-09-30 | -$362.63K 10-Q · filed 2019-11-14 | -$673.78K derived: sum of 2 quarters · filed 2019-11-14 | -$732.37K 10-Q · filed 2019-11-14 | $6.32M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||||
| 2018-06-30 | -$311.15K 10-Q · filed 2019-08-14 | -$369.74K 10-Q · filed 2019-08-14 | $6.69M derived: sum of 3 quarters · filed 2019-08-14 | $6.43M derived: sum of 4 quarters · filed 2019-08-14 | |||||||||||||
| 2018-03-31 | -$58.59K 10-Q · filed 2019-05-15 | $7.00M derived: sum of 2 quarters · filed 2019-05-15 | $6.74M derived: sum of 3 quarters · filed 2019-05-15 | $5.52M derived: sum of 4 quarters · filed 2019-05-15 | |||||||||||||
| 2017-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $6.80M derived: sum of 2 quarters · filed 2019-04-01 | $5.58M derived: sum of 3 quarters · filed 2019-04-01 | $3.53M 10-K · filed 2019-04-01 | |||||||||||||
| 2017-09-30 | -$253.97K 10-Q · filed 2018-11-14 | -$1.48M derived: sum of 2 quarters · filed 2018-11-14 | -$3.53M 10-Q · filed 2018-11-14 | $20.22M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||||||
| 2017-06-30 | -$1.22M 10-Q · filed 2018-08-14 | -$3.27M 10-Q · filed 2018-08-14 | $20.48M derived: sum of 3 quarters · filed 2018-08-14 | $17.24M derived: sum of 4 quarters · filed 2018-08-14 | |||||||||||||
| 2017-03-31 | -$2.05M 10-Q · filed 2018-05-15 | $2.05M 10-Q · filed 2017-05-10 | $21.70M derived: sum of 2 quarters · filed 2018-05-15 | $18.46M derived: sum of 3 quarters · filed 2018-05-15 | $15.03M derived: sum of 4 quarters · filed 2018-05-15 | ||||||||||||
| 2016-12-31 | $23.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $20.51M derived: sum of 2 quarters · filed 2018-04-02 | $17.08M derived: sum of 3 quarters · filed 2018-04-02 | $13.14M 10-K · filed 2018-04-02 | |||||||||||||
| 2016-09-30 | -$3.23M 10-Q · filed 2017-11-09 | $3.23M 10-Q · filed 2016-11-09 | -$6.67M derived: sum of 2 quarters · filed 2017-11-09 | -$10.61M 10-Q · filed 2017-11-09 | $10.61M 10-Q · filed 2016-11-09 | ||||||||||||
| 2016-06-30 | -$3.43M 10-Q · filed 2017-08-09 | $3.43M 10-Q · filed 2016-08-09 | -$7.38M 10-Q · filed 2017-08-09 | $7.38M 10-Q · filed 2016-08-09 | |||||||||||||
| 2016-03-31 | $3.94M 10-Q · filed 2017-05-10 | ||||||||||||||||
| 2015-12-31 | $6.48M 10-K · filed 2017-03-16 | ||||||||||||||||
| 2015-10-31 | $2.52M 10-Q · filed 2015-12-10 | $4.26M 10-Q · filed 2015-12-10 | |||||||||||||||
| 2015-09-30 | $1.68M 10-Q · filed 2016-11-09 | $5.21M 10-Q · filed 2016-11-09 | |||||||||||||||
| 2015-07-31 | $1.75M 10-Q · filed 2015-09-09 | ||||||||||||||||
| 2015-06-30 | $1.95M 10-Q · filed 2016-08-09 | $3.53M 10-Q · filed 2016-08-09 | |||||||||||||||
| 2015-04-30 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $6.66M 10-K · filed 2017-03-16 | |||||||||||||||
| 2015-03-31 | $1.58M 10-Q · filed 2016-05-10 | ||||||||||||||||
| 2015-01-31 | $1.23M 10-Q · filed 2015-03-17 | $3.78M derived: sum of 2 quarters · filed 2015-12-10 | $4.75M 10-Q · filed 2015-03-17 | $5.54M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||
| 2014-10-31 | $2.56M 10-Q · filed 2015-12-10 | $3.52M 10-Q · filed 2015-12-10 | $4.31M derived: sum of 3 quarters · filed 2017-03-16 | $5.00M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||
| 2014-07-31 | $966.51K 10-Q · filed 2015-09-09 | $1.75M derived: sum of 2 quarters · filed 2017-03-16 | $2.44M derived: sum of 3 quarters · filed 2017-03-16 | $3.19M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||
| 2014-04-30 | $785.60K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.48M derived: sum of 2 quarters · filed 2017-03-16 | $2.22M derived: sum of 3 quarters · filed 2017-03-16 | $3.00M 10-K · filed 2017-03-16 | |||||||||||||
| 2014-01-31 | $689.67K 10-Q · filed 2015-03-17 | $1.44M derived: sum of 2 quarters · filed 2015-03-17 | $2.21M 10-Q · filed 2015-03-17 | $3.06M derived: sum of 4 quarters · filed 2016-03-14 | $26.74M 10-Q · filed 2014-03-17 | ||||||||||||
| 2013-10-31 | $748.57K 10-Q · filed 2014-12-15 | $1.52M 10-Q · filed 2014-12-15 | $2.37M derived: sum of 3 quarters · filed 2016-03-14 | $2.74M derived: sum of 4 quarters · filed 2016-03-14 | $26.05M 10-Q · filed 2013-12-17 | ||||||||||||
| 2013-07-31 | $772.89K 10-Q · filed 2014-09-15 | $1.62M derived: sum of 2 quarters · filed 2016-03-14 | $1.99M derived: sum of 3 quarters · filed 2016-03-14 | $2.59M derived: sum of 4 quarters · filed 2016-03-14 | $25.30M 10-Q · filed 2013-09-17 | ||||||||||||
| 2013-04-30 | $844.52K derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $1.21M derived: sum of 2 quarters · filed 2016-03-14 | $1.82M derived: sum of 3 quarters · filed 2016-03-14 | $2.46M 10-KT · filed 2016-03-14 | $24.53M 10-K · filed 2013-06-26 | ||||||||||||
| 2013-01-31 | $369.45K 10-Q · filed 2014-03-17 | $974.02K derived: sum of 2 quarters · filed 2014-03-17 | $1.61M 10-Q · filed 2014-03-17 | $2.33M derived: sum of 4 quarters · filed 2014-03-17 | $23.69M 10-Q · filed 2013-03-18 | ||||||||||||
| 2012-10-31 | $604.57K 10-Q · filed 2013-12-17 | $1.24M 10-Q · filed 2013-12-17 | $1.96M derived: sum of 3 quarters · filed 2013-12-17 | $2.56M derived: sum of 4 quarters · filed 2013-12-17 | $23.32M 10-Q · filed 2012-12-14 | ||||||||||||
| 2012-07-31 | $637.27K 10-Q · filed 2013-09-17 | $1.36M derived: sum of 2 quarters · filed 2013-09-17 | $1.96M derived: sum of 3 quarters · filed 2013-09-17 | $2.45M derived: sum of 4 quarters · filed 2013-09-17 | $22.71M 10-Q · filed 2012-09-19 | ||||||||||||
| 2012-04-30 | $722.16K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $1.32M derived: sum of 2 quarters · filed 2013-06-26 | $1.81M derived: sum of 3 quarters · filed 2013-06-26 | $2.46M 10-K · filed 2013-06-26 | $22.08M 10-K · filed 2012-07-25 | ||||||||||||
| 2012-01-31 | $599.93K 10-Q · filed 2013-03-18 | $1.09M derived: sum of 2 quarters · filed 2013-03-18 | $1.74M 10-Q · filed 2013-03-18 | $2.21M derived: sum of 4 quarters · filed 2013-03-18 | $21.35M 10-Q · filed 2012-03-15 | ||||||||||||
| 2011-10-31 | $488.58K 10-Q · filed 2012-12-14 | $1.14M 10-Q · filed 2012-12-14 | $1.61M derived: sum of 3 quarters · filed 2012-12-14 | $2.10M derived: sum of 4 quarters · filed 2012-12-14 | $20.75M 10-Q · filed 2011-12-15 | ||||||||||||
| 2011-07-31 | $651.96K 10-Q · filed 2012-09-19 | $1.12M derived: sum of 2 quarters · filed 2012-09-19 | $1.62M derived: sum of 3 quarters · filed 2012-09-19 | $2.19M derived: sum of 4 quarters · filed 2012-09-19 | $20.26M 10-Q · filed 2011-09-19 | ||||||||||||
| 2011-04-30 | $465.30K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $963.82K derived: sum of 2 quarters · filed 2012-07-25 | $1.54M derived: sum of 3 quarters · filed 2012-07-25 | $2.68M 10-K · filed 2012-07-25 | |||||||||||||
| 2011-01-31 | $498.52K 10-Q · filed 2012-03-15 | $1.07M derived: sum of 2 quarters · filed 2012-03-15 | $2.22M 10-Q · filed 2012-03-15 | ||||||||||||||
| 2010-10-31 | $572.65K 10-Q · filed 2011-12-15 | $1.72M 10-Q · filed 2011-12-15 | |||||||||||||||
| 2010-07-31 | $1.15M 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |